Wei-ming Li

A deep learning-based system for survival benefit prediction of tyrosine kinase inhibitors and immune checkpoint inhibitors in stage IV non-small cell lung cancer patients: A multicenter, prognostic study

Huan Wang, Lu Wang, Zaiyi Liu, 2022, EClinicalMedicine.

Single‐cell transcriptome analysis reveals cellular and molecular alterations in small cell lung cancer tumors following chemotherapy

Haoyu Wang, Zhoufeng Wang, Guonian Zhu, 2023, International journal of cancer.

Explainable Machine Learning Model to Prediction EGFR Mutation in Lung Cancer

Xingyu Xiong, Ruiyuan Yang, Haoyu Wang, 2022, Frontiers in Oncology.

Association between pretreatment C-reactive protein level and survival in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis.

Dan Liu, Ruiyuan Yang, Haoyu Wang, 2023, International immunopharmacology.

Association of pretreatment neutrophil-to-lymphocyte ratio with clinical outcomes in cancer immunotherapy: An evidence synthesis from 30 meta-analyses.

Ruiyuan Yang, Haoyu Wang, Wei-ming Li, 2024, International immunopharmacology.

Incidence and risk factors of VTE in lung cancer: a meta-analysis

Ruiyuan Yang, Haoyu Wang, Wei-ming Li, 2024, Annals of medicine.

Prognostic Value of the Glasgow Prognostic Score in Non-Small Cell Lung Cancer Patients Receiving Immunotherapy: A Meta-Analysis

Ruiyuan Yang, Haoyu Wang, Cheng Cheng, 2023, Nutrition and cancer.

Risk of second primary lung cancer in patients with thyroid cancer: a meta-analysis based on big population studies

Dan Liu, Ruiyuan Yang, Yan Wang, 2023, Chinese medical journal.